Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program

Aug 26, 2021

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

Aug 16, 2021

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

Jul 29, 2021

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

Jul 20, 2021

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

Jul 12, 2021

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

Jul 8, 2021

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

Jun 22, 2021

BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

Jun 22, 2021

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

Jun 21, 2021

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

Jun 17, 2021
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...47
    Next

    OPKO HEALTH, INC.
    4400 Biscayne Boulevard
    Miami, FL 33137

    305-575-4100
    contact@opko.com

    © 2023 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap